Clinical Trial Update: Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia

View source ↗

Summary

This update reports on a completed clinical trial evaluating risk models to optimize prophylaxis schedules for children with hemophilia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Neuroscience Research Australia | Conditions: Hemophilia | Status: COMPLETED